Dermatology News

Dermatology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kopp HG et al. - Novel compounds such as bevacizumab, multi-tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, imatinib, and the thrombospondin agonist ABT 510 represent attractive partners for the above-mentioned cytostatic agents, or may even be effective single agents in the clinically advanced setting.

Related Articles

Postirradiation Sarcoma: Clinicopathologic Features and Role of Chemotherapy in the Treatment Strategy
Sarcoma, 11/23/09    Relevance Score: 92%

Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas
Modern Pathology, 11/11/09    Relevance Score: 92%

Histiocytic sarcoma with interdigitating dendritic cell differentiation: A case report with fine needle aspiration cytology and review of literature
Diagnostic Cytopathology, 10/28/09    Relevance Score: 90%

Skeletal metastasis from sarcoma: a report of three cases
European Journal of Orthopaedic Surgery & Traumatology, 10/23/09    Relevance Score: 89%

Alveolar soft-part sarcoma of the tongue in a 17-month-old
ENT Journal, 10/19/09    Relevance Score: 89%

Today in Dermatologic Oncology...keeping you current

Surgical excision of skin cancer: the importance of training
British Journal of Dermatology, 12/11/09

A definitive role for sentinel lymph node mapping with biopsy for cutaneous melanoma of the head and neck
The Surgeon - Journal of the Royal College of Surgeons at Edinburgh and Ireland, 12/11/09

Importance of clear resection margins in anorectal malignant melanoma
British Journal of Surgery, 12/11/09